In a prior study of 2782 patients hospitalized with COVID-19, CRP concentrations above the median value were associated with AKI, critical illness, and mortality compared with CRP below the median (27), illustrating that CRP can be used as an important marker for the early assessment of COVID-19 severity. This evidence concerns the gene CRP and acute kidney injury.